Fund Holdings — Samsara BioCapital, LLC

Total Portfolio Value:
$646.37M
Total Bought:
$99.76M
Total Sold:
$151.49M
Net Transaction:
-$51.73M
Notable People:
Michael Philip Dybbs
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Scholar Rock Holding Corporation(SRRK)6,788,6096,788,6090$127.63M$120.57M18.65%-$7.06M
Cargo Therapeutics Inc4,121,6894,121,6890$95.42M$92.00M14.23%-$3.42M
Mineralys Therapeutics, Inc.(MLYS)4,519,3615,074,916+555,555$38.87M$65.52M10.14%+$26.65M
Neurogene Inc.(NGNE)1,267,7901,267,7900$24.57M$64.53M9.98%+$39.96M
Nkarta, Inc.(NKTX)2,868,0353,768,035+900,000$18.93M$40.73M6.30%+$21.80M
Arcellx Inc
COMMON STOCK
460,441453,641-6,800$25.55M$31.55M4.88%+$6.00M
LENZ Therapeutics, Inc.(LENZ)01,208,473+1,208,473$0$26.99M4.17%+$26.99M
Lyra Therapeutics Inc2,780,2612,780,2610$14.57M$17.29M2.68%+$2.72M
Acelyrin Inc2,523,0222,523,0220$18.82M$17.03M2.63%-$1.79M
Avadel Pharmaceuticals PlcADR967,527967,5270$13.66M$16.34M2.53%+$2.68M
Jasper Therapeutics, Inc.(JSPR)0525,000+525,000$0$15.41M2.38%+$15.41M
Zymeworks Inc.(ZYME)1,458,8751,458,8750$15.16M$15.35M2.37%+$189.7K
Hillevax Inc799,274799,2740$12.83M$13.29M2.06%+$463.6K
ABIVAX Société AnonymeADS(ABVX)850,000850,0000$9.10M$12.15M1.88%+$3.06M
Inozyme Pharma Inc1,562,5001,562,5000$6.66M$11.97M1.85%+$5.31M
Syros Pharmaceuticals Inc1,786,4271,786,4270$13.92M$9.56M1.48%-$4.36M
Sutro Biopharma, Inc.(STRO)1,675,5791,675,5790$7.19M$9.47M1.46%+$2.28M
Rhythm Pharmaceuticals, Inc.(RYTM)172,647172,6470$7.94M$7.48M1.16%-$455.8K
Gossamer Bio, Inc.(GOSS)6,130,2686,130,2680$5.59M$7.23M1.12%+$1.64M
Janux Therapeutics, Inc.(JANX)360,414180,207-180,207$3.87M$6.78M1.05%+$2.92M
Io Biotech Inc3,640,0153,640,0150$6.84M$6.30M0.97%-$546.0K
Verona Pharma PlcADS347,500347,5000$6.91M$5.59M0.87%-$1.32M
Tango Therapeutics, Inc.(TNGX)630,000630,0000$6.24M$5.00M0.77%-$1.23M
vTv Therapeutics Inc.CL A(VTVT)40,888206,784+165,896$470.2K$4.87M0.75%+$4.40M
Immatics N.V.SHS(IMTX)396,000396,0000$4.17M$4.16M0.64%-$7.9K
Adverum Biotechnologies Inc0291,666+291,666$0$4.12M0.64%+$4.12M
Prime Medicine, Inc.(PRME)470,304540,304+70,000$4.17M$3.78M0.59%-$384.8K
Day One Biopharmaceuticals I
COM
196,425196,4250$2.87M$3.24M0.50%+$377.1K
Cypherpunk Technologies Inc.(CYPH)669,303669,3030$2.77M$1.78M0.28%-$993.9K
Igm Biosciences Inc154,664154,6640$1.29M$1.49M0.23%+$207.3K
Bolt Biotherapeutics Inc1,049,1531,049,1530$1.18M$1.47M0.23%+$293.8K
Terns Pharmaceuticals Inc202,348202,3480$1.31M$1.33M0.21%+$14.2K
Aclaris Therapeutics, Inc.(ACRS)696,171696,1710$731.0K$863.3K0.13%+$132.3K
Viracta Therapeutics Inc689,709689,7090$393.1K$703.5K0.11%+$310.4K
Allakos Inc172,089172,0890$469.8K$216.8K0.03%-$253.0K
Kronos Bio Inc78,13178,1310$97.7K$101.6K0.02%+$3.9K
Allovir Inc82,33682,3360$56.0K$62.2K0.01%+$6.2K
Nuvation Bio Inc.W EXP 07 07 202(NUVB)133,333133,3330$8.0K$40.3K0.01%+$32.3K
Surrozen, Inc.W EXP 08 01 203(SRZN)99,99999,9990$1.9K$3.0K0.00%+$1.1K
Graphite Bio Inc8,459,3140-8,459,314$22.16M$0—-$22.16M
PepGen Inc.(PEPG)436,8130-436,813$2.97M$0—-$2.97M
Rain Oncology Inc2,034,5520-2,034,552$2.44M$0—-$2.44M
Rayzebio Inc1,845,9480-1,845,948$114.76M$0—-$114.76M
Science 37 Holdings Inc45,0000-45,000$240.3K$0—-$240.3K
Page 1 of 1
Samsara BioCapital, LLC — 13F Holdings — Q1 2024 | TickerTrail